Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

HER2-negative Breast Cancer × trastuzumab deruxtecan × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 51 Neoplasm Metastasis 20 Carcinoma, Non-Small-Cell Lung 10 Stomach Neoplasms 8 Brain Neoplasms 8 Colorectal Neoplasms 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Salivary Gland Neoplasms 3 Recurrence 3 Pancreatic Neoplasms 3 Neoplasms 3 Adenocarcinoma 3 Prostatic Neoplasms 2 Meningeal Carcinomatosis 2 HER2-positive Gastric Cancer 2 Esophageal Neoplasms 2 Breast Cancer With Brain Metastasis 2 Advanced Breast Cancer 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Solid Cancer 1 Small Cell Lung Carcinoma 1

Interventions

pembrolizumab 1 Paclitaxel 1 Doxorubicin 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡